Varenicline tartrate

Varenicline tartrate is a premium-grade, high-purity selective α4β2 nicotinic acetylcholine receptor partial agonist carrying CAS number 375815-87-5. Refined under strict pharmaceutical quality compliance, this active pharmaceutical ingredient (API) exhibits exceptional efficacy in the development of specialized smoking cessation therapeutic treatments. Therefore, it provides reliable stability in sensitive medicinal formulations and ensures consistent therapeutic activity. Consequently, it serves as an ideal core choice for specialized pharmaceutical manufacturing lines, clinical research, and modern medical synthesis processes globally.

SKU: 375815-87-5 Category: Tags: ,
Description
Varenicline tartrate (CAS 375815-87-5) represents an elite-grade pharmaceutical agent refined under strict industrial production guidelines. This specific compound fulfills advanced pharmaceutical research and medicinal manufacturing standards perfectly.
Zyntex supplies high-purity Varenicline tartrate tailored for global pharmaceutical manufacturing plants. It is ideal for clinical research laboratories and specialized therapeutic production lines.
Functioning as a selective partial agonist, it regulates neurological nicotinic receptors through refined molecular binding properties. Furthermore, it delivers precise powder profiles that ensure uniform batch integration. Its strictly minimized impurity variations and optimized molecular structure make it an ideal selection. Consequently, it fits sensitive medicinal formulation profiles and continuous pharmaceutical blending perfectly. Accordingly, production engineers specify this active substance to stabilize modern therapeutic carriers. This practice maintains exact chemical integrity across continuous processing cycles.

Therapeutic Efficacy and Stability

Excellent thermal stability and outstanding biological affinity provide a distinct operational edge. This advantage is crucial when engineering modern high-performance smoking cessation formulations. This active pharmaceutical solid operates by facilitating the systemic regulation of targeted nicotinic pathways. Thus, it successfully enhances the therapeutic profiling of targeted medicinal matrices. It supplies the exact chemical mechanisms required to induce rapid synthetic steps. As a consequence, it does this without altering raw mass density uniformity.

It assists formulation experts in maintaining strict active concentration uniformity. This balance is critical across high-speed pharmaceutical synthesis operations and continuous filling lines. Hence, it mitigates trace impurity risks within automated volumetric dosing machinery. For instance, specialized production facilities incorporate this refined substance. It acts as a core active component in targeted neurological management and specialized treatment cycles. Consequently, it maximizes the technical throughput of automated formulation machinery. Consequently, Zyntex coordinates clean-room synthesis paths to eliminate downstream moisture-induced alterations from your factory schedule.

Homogeneity and Logistics

In addition to this, Zyntex coordinates climate-controlled logistics for manufacturing operations. This service supports advanced pharmaceutical synthesis centers globally. The compound maintains its refined molecular geometry under strict storage parameters. Therefore, it prevents temperature-induced degradation during automated mechanical blending steps. It advances contemporary medicinal engineering by providing a thoroughly analyzed, highly predictable raw material.

Primary Industrial Sectors for Varenicline Tartrate

This high-purity active compound delivers crucial technical value within these four primary industrial sectors:

💊 Pharmaceuticals

Primary ingredient for advanced smoking cessation and anti-addiction formulations.

🧪 Clinical Research

Essential reagent for studying nicotinic receptor partial agonist kinetics.

🧬 Biotechnology

Active component in specialized neurological growth control mediums.

🔬 Analytical Assays

Reference material for validating pharmaceutical ingredient potency.

Technical Specifications

ParameterStandard Value
Product NameVarenicline tartrate
Assay / PurityMin 99.0%
AppearanceWhite to off-white powder
CAS Number375815-87-5

⚠️ SAFETY & HANDLING (Moderate Hazard): Varenicline tartrate is a potent pharmaceutical agent. Handling: Use appropriate PPE (gloves, safety goggles, respiratory protection) and ensure adequate ventilation to prevent dust exposure. Storage: Store in a cool, dry, and dark area. Keep containers tightly closed. Review the full Safety Data Sheet (SDS) for detailed facility protocols.